so has paved the way for today's Bsecond generationĉ hitosans with better-defined structures and more reliable functions than the early ill-defined Bfirst-generationm aterials. This special volume of AAPS PharmSciTech, entitled BTheme: Recent Trends in the Development of ChitosanBased Drug Delivery Systems,^includes a topical collection of a total of 14 papers including both articles from EUCHIS/ ICCC 2015 plus others freely contributed manuscripts that successfully passed the normal rigorous peer review process addressing a diversity of topics.
The first article describes the advantages of chitosan matrices for the development of buccal mucoadhesive devices. These types of biopolymeric formulations generate hydrophilic networks that contain numerous polar functional groups that interact with biological structures. Tejada et al. [1] describe the formulation of miconazole nitrate buccal films using chitosan, pectin, and hydroxypropylmethyl cellulose to form such polymeric matrices. Chitosan:hydroxypropylmethyl cellulose films were found to be the most appropriate formulations in terms of folding endurance, mechanical properties, and adhesiveness. The in vitro antifungal activity showed a significant activity of the model drug loaded into those films.
Reduction of particle size is an attractive and widely used technique to improve the aqueous solubility of poorly watersoluble compounds belonging to the class II of the Biopharmaceutical Classification System. Herein, Priotti et al. [2] reported the preparation of albendazole microcrystals using the bottom-up technology based on chitosan and cellulose derivatives. The concentration of polymers, the influence of surfactant in the crystals, the variables area under the curve, albendazole microcrystal solubility, and drug released were analyzed with a three-way ANOVA. The in vitro studies demonstrated the suitability of this approach for further in vivo studies.
Microencapsulation is still one of the most suitable procedures to prepare controlled drug delivery systems, and the type of selected polymers used as carrier is one of the key factors in this issue. Herein, Khattab et al. [3] explored the delivery of ranitine HCl from mucoadhesive polymeric microspheres using chitosan and two cellulose derivatives as wall materials. A 3 × 22 full factorial design was applied to find the optimized formulation in terms of particle size, swelling index, drug entrapment efficiency, and bioadhesion drug release. In vivo protective and healing effects of the optimized formula against gastric ulcers were investigated, also.
Chitosan and its synthetic derivatives have been used as biomaterial in several fields including tissue engineering due to, mainly, its good biocompatibility and biodegradability. In this issue, an interesting application of chitosan derivatives has been described by Martínez-Campos et al. [4] . Three types of chitosan-based films were prepared and evaluated, in terms of cell adhesion and proliferation, using pre-myoblastic cells and B16 cells as a tumoral model. A differential cell behavior was detected on chitosan films due to their different surface modification. B16 cells have shown lower vinculin expression when cultured on sulfonated chitosan films.
In the last decades, different nanotechnologies have been employed to improve the technological and biopharmaceutical performance of hydrophobic drugs through the formulation of nano-drug delivery systems. In particular, drug nanosuspensions emerged as an attractive approach to deliver poorly water-soluble molecules. Kassem et al. [5] described the preparation of nanosuspensions of lacidipine, a highly lipophilic calcium channel blocker. A Box-Behnken design was used to optimize the formulation variables. A significantly improved dissolution rate due to particle size reduction and decreased crystallinity was obtained, suggesting that this novel alternative could be a valuable tool to improve oral absorption of lacidipine.
Another application of chitosan in the nanotechnology field has been described by Zhao et al. [6] . Timolol maleate, a compound to treat high pressure inside the eye due to glaucoma, was incorporated into chitosan nanoparticles. Nano-formulations were prepared and optimized via a fourlevel and three-factor Box-Behnken statistical experimental design. In vitro transcorneal permeation study, confocal microscopy, and in vivo pharmacodynamic were performed, and the results indicated the suitability of the methodology for the treatment of ocular diseases.
As already mentioned, polymeric mucoadhesion is an interesting and valuable property in the design of drug delivery systems. In this regard, chitosan is able to form electrostatic complexes under acidic medium with the anionic groups of the mucus gel layer. As a consequence, an extended residence time of the mucoadhesive polymeric device at the site of drug absorption can be observed. Herein, Alkhader et al. [7] investigated the properties of a mucoadhesive chitosan-pectinate nano-formulation for colonic delivery of curcumin. A detailed physicochemical characterization was carried out and it was found that 80% release of curcumin was achieved in pectinase-enriched medium.
In recent years, chitosan and its derivatives have gained increased importance for wound healing, which consist of different steps to repair the damage of tissue and replacement of lost skin. Aslan et al. [8] described the formulation of interleukin-2-loaded chitosan-based nanogels for the healing of wound incision in rats. Artificial neural network models were developed using selected input parameters where particle size was an output parameter for interleukin-2-free nanogels. Wound healing effect of these nanogels was evaluated by determining the malondialdehyde (MDA) and glutathione (GSH) levels of wound tissues in rats. Interleukin-2 was released slowly after the initial burst effect and in vivo study showed that this approach was effective for improving wound healing in rats.
Regulation of gene expression is generally described as gene silencing and it is related with the cell ability to prevent the expression of a certain gene. One of the most useful approach to avoid the gene expression is by means of by small interfering RNA (siRNA). Herein, Salva et al. [9] deeply investigated the in vitro gene expression of chitosanbased siRNA nanoplexes to inhibit cell proliferation in proliferative glomerulonephritis disease. After transfection, chitosan nanoplexes successfully diminished cell proliferation and cell migration in the rat mesangial cells by inhibiting the grow factors suggesting that the formulation of chitosanbased gene delivery system is a promising tool to treat renal disease.
Another work based on the mucoadhesion of chitosan is herein reported by Naz et al. [10] . Unmodified chitosan was covalently modified by thioglycolic acid (TGA) and cysteine to design multifunctional thiolated polymeric films for the delivery of fluconazole, an anfigungal agent. The thiolated mucoadhesive films were characterized for water-uptake capacity, mucoadhesion, permeability study, and in vitro drug release profile. Through the formulation of these thiopolymeric devices, both permeation and film mucoadhesion were highly increased while a controlled fluconazole release was obtained compared to the unmodified formulation.
Next, Mostafa et al. [11] described another application of chitosan as biomaterial carrier by formulating chitosannanobioactive glass scaffolds loaded with ciprofloxacin for bone tissue engineering. The morphology of the matrices was fully characterized indicating that the chitosan-bioactive glass formulation (1:2 ratio) was the most suitable scaffold composition for controlled drug release. The authors also confirmed that the optimized polymeric matrix showed a significant biocompatibility by inducing cell growth and differentiation.
The efficient and safe protein delivery from biopolymeric devices is an emerging field in pharmaceutical research; however, several challenges need to be resolved including the interactions between the carrier and the protein and its release from the polymeric network. In this context, Becerra et al. [12] reported the preparation of chitosan-based films to deliver ovalbumin, as model protein. A systematic physicochemical study was performed to evaluate whether the polymeric degree of acetylation would influence both the film crystalline structure and its release characteristics. The authors confirmed that hydrophilic/hydrophobic interactions related with the chitosan degree of acetylation exhibit a significant influence over the matrix swelling behavior and further release of the model protein.
The formulation of sustained-release dosage forms involves the formation of crosslinked polymeric networks, which may avoid a high and not desirable burst release. However, more information to find the suitable formulation in terms of production procedure, size distribution, type of crosslinking agent, and drug release rate is still required. In this issue, Rodriguez et al. [13] reported the preparation of chitosan microparticles crosslinked with different ratios of sodium tripolyphosphate microparticles. The impact of the agitation rate, oil phase concentration, emulsifier to oil ratio, and polymer concentration over the loading and further release of acetylsalicylic acid, a model drug, was analyzed in detail. The authors reported that size regulation of aqueous droplets in the oil phase was achieved by using a right balance among the components of the formulation.
Chitosan is also widely used as starting material for the preparation of microbeads. An original research by Xing et al. [14] reported the successful encapsulation of specific egg yolk immunoglobulin (IgY) to avoid the binding of clostridium difficile toxins to the colonic mucosa. The authors confirmed that the chitosan-Ca pectinate microbead formulations exhibited promising colon-targeting properties, showing low drug release at both the stomach and small intestine while a fast release was observed in colon. It was concluded that these chitosan-based microbeads would represent a convenient approach for specific immunoglobulin release into the colon.
The advantages of pulmonary nano-drug delivery systems are mainly based on a better effectiveness to the target site, improved drug efficacy, and increased bioavailability. Herein, Komenek et al. [15] designed gold-based nanoparticles stabilized by quaternized chitosan-gallic acid-folic acid for the treatment of lung cancer. In vitro cytotoxicity studies, cellular uptake, and localization of such nanocarrier were deeply described by the authors. As a conclusion, they found that this gold-based nanocarrier may enhance the cellular uptake and reduce the accumulation of nanoparticles in the pulmonary tract leading to less toxicity profile than other nanocarriers.
